Delivery Order SPE2DB22D2005-SPE2DB25FJJH8

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,159.51, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,810,234 units of Fexofenadine HCL 180 mg tablets, with a total ceiling value of $21,068.52 and a period of performance through December 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.97 Firm Fixed Price delivery order contract is for the supply of 4,565,122,465 units of Fexofenadine HCL 180 mg tablets. The contract has a period of performance through July 12, 2024 and was awarded on July 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order federal contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,062 units of the drug Fexofenadine HCL 180 mg tablets, with a ceiling value of $1,844.16. It is a firm fixed-price contract with a period of performance through July 5, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award, with a value of $2,168.70, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,890,572 tablets of Fexofenadine HCl 180 mg. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 23, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $4,481.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,675,808 units of Fexofenadine HCL 180 mg Tablets, with a completion date of September 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a Delivery Order worth $4,248.50 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,284,157 units of Fexofenadine HCL 180 mg tablets in 500-count packages. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,337.28, is for the delivery of 4,567,094,436 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation or subcontractors....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,206.90 firm fixed-price delivery order is for the supply of 4,564,852,598 units of Fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $1,903.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,563,346,371 units of Fexofenadine HCL 180 mg Tablets. The contract has a period of performance through January 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJJH8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,002.96, is for the delivery of 4,567,485,237 units of the prescription drug Fexofenadine HCl 180 mg tablets.

The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/5/25, 10:04 AM